Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI

Early assessment of neoadjuvant systemic therapy (NAST) response for triple-negative breast cancer (TNBC) is critical for patient care in order to avoid the unnecessary toxicity of an ineffective treatment. We assessed functional tumor volumes (FTVs) from dynamic contrast-enhanced (DCE) MRI after 2...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancers 2023-02, Vol.15 (4), p.1025
Hauptverfasser:	Panthi, Bikash, Adrada, Beatriz E, Candelaria, Rosalind P, Guirguis, Mary S, Yam, Clinton, Boge, Medine, Chen, Huiqin, Hunt, Kelly K, Huo, Lei, Hwang, Ken-Pin, Korkut, Anil, Lane, Deanna L, Le-Petross, Huong C, Leung, Jessica W T, Litton, Jennifer K, Mohamed, Rania M, Musall, Benjamin C, Pashapoor, Sanaz, Patel, Miral M, Perez, Frances, Son, Jong Bum, Thompson, Alastair, Valero, Vicente, Wei, Peng, White, Jason, Xu, Zhan, Pinsky, Lawrence, Tripathy, Debu, Yang, Wei, Ma, Jingfei, Rauch, Gaiane M
Format:	Artikel
Sprache:	eng
Schlagworte:	Breast cancer Cancer therapies Chemotherapy Estrogens Magnetic resonance imaging Medical prognosis Methods Neoadjuvant therapy Patient outcomes Patients Toxicity Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!